pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3911 |
Genomic Coordinates | chr9: 127690687 - 127690795 |
Description | Homo sapiens miR-3911 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3911 | |||||||||||||||||||||||||||
Sequence | 12| UGUGUGGAUCCUGGAGGAGGCA |33 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | EFNB1 | ||||||||||||||||||||
Synonyms | CFND, CFNS, EFB1, EFL3, EPLG2, Elk-L, LERK2 | ||||||||||||||||||||
Description | ephrin B1 | ||||||||||||||||||||
Transcript | NM_004429 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on EFNB1 | |||||||||||||||||||||
3'UTR of EFNB1 (miRNA target sites are highlighted) |
>EFNB1|NM_004429|3'UTR 1 GTGCCCGGCACGGCCTCAGGCCCCCGAGGGACAGTCGGCCTGGACCGGACCTCTCCTTTCGCCCCCACACCCCCTCCCCT 81 TGCCAGCTGTGCCCACCTTTGTATTTAGTTTTGTAGTTTCTTGGCTTTTATAATCCCCCTTTTTCCCTGCCCCCTGGGCT 161 TCGGAGGGGGGTGCTTGTGCCCCTAACCCCCATGCTCTTGTGCCTTCCCCCTCTGGCCAGGCCTCTGGGCTCCGTGGGGG 241 CGCCCCTTCTTGGAAGGCAGGGCTGGACACTGATGGACAGCAGGCAGGGAGACAGTCCCCTGGCCCTGCCCCTCCCTCGC 321 CCCCCTTGCCACCTTCCCAGGACTGCTTGTCCGCTATCATCACTGTTTTTAATGCTTTTGTGTTCATTTTTTAGCTGTCA 401 ACTCATTTTCATCTGTTTTTTGAAGAAAAATGGAAAAATGTAAAAGGCAGCCCCTCCCCAGGCTTTGTGAGCCTGGCCCA 481 AGCCAGTACAAGAGGGCCTGGGGCACGATGTGGTCAGCCAGGAAGCATAGGATGCCATTTCTTTTATAGATTCCTTGGTA 561 TTTCTGGTGGGGTAAGGGGCAGGCCAGGGCTGTTCACGCCCATGAGGGAAGAGGAAAGTGCCACTGGGCAAGGTGTCCCA 641 CCCTCCCCTCCTGACCCTCCTACGAGGCTTATCCTGGCAATGGGGTAGTCACTGCCACCCTTCCACACACACACACACAC 721 ACACACACACAAAAAAAAATCCCTTCCTTGTGGGATTCTTGGGCATCTCCTGCCTCCCTCACTCTCACGGTAATTAATGT 801 CTTAATTGGCTGTTGCCTGGGGAACAGGAGAGCTGCTGCAGGCAGATGACCTCATGGGGGGTGGAGGGAGGTGAGGTGCC 881 CAGGTGGCTATTTGCCCTGCAGAGCTGGGAGTTTCACCCCCACCCCCCACCCTGTTCTCTCCTTACCTTTGGCATCCTTT 961 GGCCTGGTGGGGAAACAGAGGCCCAGGGTGGAGACCTAAGCGGGTATAAGACCAGGTGGCCTGCTCCTTTTCTGGGCCCT 1041 AGCACAGGTGGGTAACCCCCACCCAACCCAGCTCCTGCTGCTGTCCCAGTCTTGGGCTGGGGCCTGGAAAGAGGAAGAGG 1121 CTGCCTGGGGCTGGGCCAGCCCGCTGTGCACTTTGACCCCAGTTCCTTGCCAGCACGGCTGCTAACAGACTGCCACTTGA 1201 GTGCGCCTTGCAGGCACTCCCAGAGCAGCCATGGAAGGAGCTGGCCCTCACACCATCCACCTCCACACTGCCTCCTGGCC 1281 AGCTGCCCACCCCAGTGCCAGGTGGGAGAGGGAGCAGAACAGCCAGCCCCTTCCAGGTGGCAGTCGGAAGGGTTTTTGTT 1361 TTTGTTTCTGTTGCCATTTGTGTAAATACTAGTCTTTTTGGAAAAAAAATAATGTAAAGATGTTTTGTATAAACTCTGAA 1441 TTATTTTCTTGTTGCTTTTTTCTTAGAAAAAAATGAGAACTAAAAAAAAAAAATTAACCACATGGAGAAAAAAAAAAAAA 1521 AAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Cardiac Tissues | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM2202481. RNA binding protein: AGO2. Condition:S6_LV_61yo_Male_AGO2_bound_RNA
... - Spengler RM; Zhang X; Cheng C; McLendon JM; et al., 2016, Nucleic acids research. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.
- Spengler RM; Zhang X; Cheng C; McLendon JM; et al.- Nucleic acids research, 2016
MicroRNAs (miRs) have emerged as key biological effectors in human health and disease. These small noncoding RNAs are incorporated into Argonaute (Ago) proteins, where they direct post-transcriptional gene silencing via base-pairing with target transcripts. Although miRs have become intriguing biological entities and attractive therapeutic targets, the translational impacts of miR research remain limited by a paucity of empirical miR targeting data, particularly in human primary tissues. Here, to improve our understanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-throughput methods to globally profile miR:target interactions in human heart tissues. We deciphered Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across >2200 target transcripts. Our initial exploration of this interactome revealed an abundance of miR target sites in gene coding regions, including several sites pointing to new miR-29 functions in regulating cardiomyocyte calcium, growth and metabolism. Also, we uncovered several clinically-relevant interactions involving common genetic variants that alter miR targeting events in cardiomyopathy-associated genes. Overall, these data provide a critical resource for bolstering translational miR research in heart, and likely beyond.
LinkOut: [PMID: 27418678]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_004429 | 3UTR | ACACACACACACACACACACACAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000204961.4 | 3UTR | CCCUCACACCAUCCACCUCCACACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
70 hsa-miR-3911 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT207399 | MAT2A | methionine adenosyltransferase 2A | 2 | 6 | ||||||||
MIRT284537 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT291946 | TPM4 | tropomyosin 4 | 2 | 2 | ||||||||
MIRT293609 | PVR | poliovirus receptor | 2 | 2 | ||||||||
MIRT357688 | PAIP2 | poly(A) binding protein interacting protein 2 | 2 | 2 | ||||||||
MIRT451607 | MEIS3P1 | Meis homeobox 3 pseudogene 1 | 2 | 2 | ||||||||
MIRT452110 | IFITM1 | interferon induced transmembrane protein 1 | 2 | 2 | ||||||||
MIRT457804 | KLHL25 | kelch like family member 25 | 2 | 2 | ||||||||
MIRT462730 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT463219 | ZNF131 | zinc finger protein 131 | 2 | 2 | ||||||||
MIRT464141 | VPS28 | VPS28, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT467582 | SLC7A5 | solute carrier family 7 member 5 | 2 | 6 | ||||||||
MIRT470824 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT474230 | LCLAT1 | lysocardiolipin acyltransferase 1 | 2 | 2 | ||||||||
MIRT478989 | COLGALT1 | collagen beta(1-O)galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT479462 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT483558 | SYT2 | synaptotagmin 2 | 2 | 2 | ||||||||
MIRT484483 | SLC9A1 | solute carrier family 9 member A1 | 2 | 2 | ||||||||
MIRT485224 | PRICKLE1 | prickle planar cell polarity protein 1 | 2 | 2 | ||||||||
MIRT490356 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 4 | ||||||||
MIRT493177 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT509802 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 4 | ||||||||
MIRT511815 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT512254 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 6 | ||||||||
MIRT513025 | GPT2 | glutamic--pyruvic transaminase 2 | 2 | 2 | ||||||||
MIRT519640 | ZNF772 | zinc finger protein 772 | 2 | 4 | ||||||||
MIRT531178 | SIGLEC12 | sialic acid binding Ig like lectin 12 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT537870 | EDA2R | ectodysplasin A2 receptor | 2 | 2 | ||||||||
MIRT551914 | IGLON5 | IgLON family member 5 | 2 | 2 | ||||||||
MIRT558359 | DMTF1 | cyclin D binding myb like transcription factor 1 | 2 | 2 | ||||||||
MIRT559771 | URGCP-MRPS24 | URGCP-MRPS24 readthrough | 2 | 4 | ||||||||
MIRT559813 | ZNF83 | zinc finger protein 83 | 2 | 2 | ||||||||
MIRT561999 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT565754 | SERTAD2 | SERTA domain containing 2 | 2 | 2 | ||||||||
MIRT569423 | DCAF8 | DDB1 and CUL4 associated factor 8 | 2 | 2 | ||||||||
MIRT569845 | RGS5 | regulator of G protein signaling 5 | 2 | 2 | ||||||||
MIRT606928 | CDK15 | cyclin dependent kinase 15 | 2 | 2 | ||||||||
MIRT607616 | TMEM130 | transmembrane protein 130 | 2 | 4 | ||||||||
MIRT607629 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT607885 | SATB1 | SATB homeobox 1 | 2 | 2 | ||||||||
MIRT607942 | SSX2 | SSX family member 2 | 2 | 4 | ||||||||
MIRT608017 | CARNS1 | carnosine synthase 1 | 2 | 4 | ||||||||
MIRT608036 | UBLCP1 | ubiquitin like domain containing CTD phosphatase 1 | 2 | 2 | ||||||||
MIRT608063 | SSX2B | SSX family member 2B | 2 | 4 | ||||||||
MIRT608558 | SBK1 | SH3 domain binding kinase 1 | 2 | 6 | ||||||||
MIRT608915 | NCDN | neurochondrin | 2 | 6 | ||||||||
MIRT615876 | HIF1AN | hypoxia inducible factor 1 alpha subunit inhibitor | 2 | 4 | ||||||||
MIRT618023 | ELFN1 | extracellular leucine rich repeat and fibronectin type III domain containing 1 | 2 | 2 | ||||||||
MIRT620505 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT628101 | IL1RAPL1 | interleukin 1 receptor accessory protein like 1 | 2 | 2 | ||||||||
MIRT628700 | ZNF548 | zinc finger protein 548 | 2 | 2 | ||||||||
MIRT630658 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT643508 | ZNF28 | zinc finger protein 28 | 2 | 2 | ||||||||
MIRT646379 | SLC22A6 | solute carrier family 22 member 6 | 2 | 2 | ||||||||
MIRT660041 | C15orf61 | chromosome 15 open reading frame 61 | 2 | 2 | ||||||||
MIRT687700 | KRR1 | KRR1, small subunit processome component homolog | 2 | 2 | ||||||||
MIRT688858 | CAMKK2 | calcium/calmodulin dependent protein kinase kinase 2 | 2 | 2 | ||||||||
MIRT690443 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT690456 | ZNF33A | zinc finger protein 33A | 2 | 2 | ||||||||
MIRT693796 | RHOG | ras homolog family member G | 2 | 2 | ||||||||
MIRT694274 | ZNF529 | zinc finger protein 529 | 2 | 4 | ||||||||
MIRT697697 | WAC | WW domain containing adaptor with coiled-coil | 2 | 2 | ||||||||
MIRT700242 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT701836 | MRPL37 | mitochondrial ribosomal protein L37 | 2 | 2 | ||||||||
MIRT704255 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT707203 | SDK2 | sidekick cell adhesion molecule 2 | 2 | 2 | ||||||||
MIRT710365 | CREB5 | cAMP responsive element binding protein 5 | 2 | 2 | ||||||||
MIRT711943 | WDFY1 | WD repeat and FYVE domain containing 1 | 2 | 2 | ||||||||
MIRT715496 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT719250 | MS4A1 | membrane spanning 4-domains A1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|